Host A(2B) adenosine receptors promote carcinoma growth.

Neoplasia : an International Journal for Oncology Research
Sergey RyzhovIgor Feoktistov

Abstract

Recent studies suggest that tumor-infiltrating immune cells can benefit the tumor by producing factors that promote angiogenesis and suppress immunity. Because the tumor microenvironment is characterized by high adenosine levels, we hypothesized that the low-affinity A(2B) adenosine receptor located on host immune cells may participate in these effects. In the current study, we tested this hypothesis in a Lewis lung carcinoma isograft model using A(2B) receptor knockout (A(2B)KO) mice. These mice exhibited significantly attenuated tumor growth and longer survival times after inoculation with Lewis lung carcinoma compared to wild type (WT) controls. Lewis lung carcinoma tumors in A(2B)KO mice contained significantly lower levels of vascular endothelial growth factor (VEGF) compared to tumors growing in WT animals. This difference was due to VEGF production by host cells, which comprised 30 +/- 2% of total tumor cell population. Stimulation of adenosine receptors on WT tumor-infiltrating CD45+ immune cells increased VEGF production fivefold, an effect not seen in tumor-associated CD45+ immune cells lacking A(2B) receptors. In contrast, we found no significant difference in VEGF production between CD45- tumor cells isolated from W...Continue Reading

Citations

Jul 28, 2010·Oncogene·J Stagg, M J Smyth
Nov 26, 2011·Cancer Immunology, Immunotherapy : CII·Adam T WaickmanJonathan D Powell
Mar 21, 2012·The Journal of Pharmacology and Experimental Therapeutics·Sergey RyzhovIgor Feoktistov
Aug 14, 2012·Pharmacological Reviews·Geoffrey BurnstockJean-Pierre Timmermans
Jan 22, 2013·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Michail Sitkovsky, Akio Ohta
Jun 26, 2013·Purinergic Signalling·Geoffrey Burnstock, Francesco Di Virgilio
Aug 8, 2013·Journal of Leukocyte Biology·Balázs KoscsóGyörgy Haskó
Jan 31, 2014·International Journal of Molecular Sciences·Sandeep ShethVickram Ramkumar
Jul 15, 2015·Molecular Diversity·Alfonso Pérez-GarridoMarta Teijeira Bautista
Jan 26, 2016·Immunotherapy·David AllardJohn Stagg
Apr 12, 2016·Frontiers in Immunology·Akio Ohta
Jan 25, 2017·Scientific Reports·Andrey A BobkoValery V Khramtsov
Oct 24, 2017·Nature Reviews. Cancer·Dipti VijayanMark J Smyth
Oct 4, 2017·Angewandte Chemie·Bayard R HuckKlaus Urbahns
Apr 13, 2018·International Journal of Molecular Sciences·Tiziana VaisittiSilvia Deaglio
Jan 24, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jessica L BowserHolger K Eltzschig
Jul 25, 2019·Current Pharmaceutical Design·Sarapynbiang MarweinPratap C Acharya
Oct 20, 2019·International Journal of Molecular Sciences·Zhan-Guo Gao, Kenneth A Jacobson
May 1, 2020·Frontiers in Immunology·Jerry B HarveyJessica L Bowser
Oct 19, 2013·Molecular Pharmacology·Sergey RyzhovIgor Feoktistov
Nov 15, 2013·Nature Reviews. Cancer·Luca AntonioliGyörgy Haskó
May 30, 2014·Expert Review of Clinical Immunology·Sylvia Muller-HaegeleTheresa L Whiteside
Mar 19, 2014·The Journal of Pharmacology and Experimental Therapeutics·Sonja HinzChrista E Müller
Mar 11, 2016·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Elham SafarzadehMehdi Yousefi
Sep 9, 2016·Frontiers in Chemistry·Ying Sun, Pingbo Huang
Jun 22, 2019·Immunotherapy·Siqi ChenBin Zhang
Sep 11, 2019·Immune Network·Samaneh Arab, Jamshid Hadjati
Mar 17, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·György Haskó, Pál Pacher
Nov 26, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Caglar CekicJoel Linden
Aug 29, 2013·International Journal of Cancer. Journal International Du Cancer·Bertrand AllardJohn Stagg
May 7, 2014·Expert Opinion on Therapeutic Targets·Bertrand AllardJohn Stagg
Nov 1, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sergey RyzhovIgor Feoktistov
Mar 5, 2017·Immunological Reviews·Bertrand AllardJohn Stagg
Jul 30, 2014·Frontiers in Immunology·Akio Ohta, Michail Sitkovsky
May 21, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Sabrina TalianiGiovanni Greco
Mar 28, 2020·Cells·Wiwin Is EffendiYoshihiro Nishimura
Jun 10, 2020·Nature Reviews. Clinical Oncology·Bertrand AllardJohn Stagg
Jan 15, 2013·Purinergic Signalling·Qiang WeiKenneth A Jacobson
May 4, 2011·The Journal of Clinical Investigation·Long WangBin Zhang
Jan 23, 2016·The Journal of Pharmacology and Experimental Therapeutics·Elizabeth A VecchioLauren T May
Aug 17, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sergey V RyzhovSergey V Novitskiy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.